News and Media

Dana Singiser is a regular source for media commentary and background interviews. She has provided extensive background information and commentary for top media outlets as well as industry-specific publications. She is a regular presenter at conferences and webinars, and authors research papers and industry analysis.

Journalists can schedule an interview or background briefing by contacting Loretta@CaminoPR.com.

Press

Authored

ARTICLE

October 27, 2025

ARTICLE

Supporting frontline women amid COVID-19

Authored by Dana Singiser.

April 27, 2020

Featured in

ARTICLE

South Carolina Bill Tees Up Contraception Access Court Battle

Dana Singiser, the lead reproductive health care policy and legislative leader at the Contraception Access Initiative, said the South Carolina bill is an example of a trend that “reflects how anti-abortion groups are really running anti-contraception campaigns” that aim to “redefine pregnancy and abortion.”

October 7, 2025

PODCAST

Birth control use is up since FDA approved over-the-counter pill

“While having Opill over the counter is historic and important, and this study shows the potential impact for increasing availability, it still leaves more than 90% of birth control pill users out of the equation.” — Dana Singiser

August 18, 2025

The GOP budget bill threatens to defund Planned Parenthood

“By taking a sledgehammer to Medicaid, we estimate that 2.7 million women of reproductive age will lose access to contraceptive care, and another 1.4 to 2 million women of reproductive age would lose access to contraceptive care due to the attacks on the Affordable Care Act.” — Dana Singiser

July 4, 2025

PODCAST
ARTICLE

What Would the Future of Birth Control Be Under Trump? Ask Texas.

Trump broadened the exemption even further in his first term, allowing employers to decline to provide birth control based on moral, not just religious, objections. “It opens the door wide for any employer that provides health insurance to pick and choose what kind of contraception they would like to cover,” says Dana Singiser, cofounder of the Contraceptive Access Initiative.

October 31, 2024

ARTICLE

What does the mifepristone case mean for Plan B? The difference between the two explained.

"Regardless of the result, it will not have an immediate impact on emergency contraception," Dana Singiser, co-founder of the Contraceptive Access Initiative, said of Tuesday's case.

March 26, 2025

First over-the-counter birth control pill in the U.S. expands access to contraception

Dana Singiser, co-founder of Contraception Access Initiative, a nonprofit working to increase access to contraception, said that over-the-counter access is a “pivotal milestone,” particularly as getting contraception has become a more important consideration amid increased restrictions on abortion.

“As abortion bans are being passed across the country, it is even more important for people to be empowered to not get pregnant if that’s what they want,” Singiser said.

March 14, 2024

ARTICLE
ARTICLE

Over-the-Counter Birth Control Fuels Push for Federal Coverage

"Opill’s availability is cause for “celebration,” but “we also are laser focused on making sure that insurance covers OTC contraception like Opill at no cost, and also that we find alternative pathways for people who don’t have insurance and who have low income,” said Dana Singiser, co-founder of the nonprofit Contraceptive Access Initiative and a partner at Keefe Singiser Partners.

March 6, 2024

ARTICLE

Republicans are taking aim on contraception — and they’d rather you didn’t know

"Opill’s availability is cause for “celebration,” but “we also are laser focused on making sure that insurance covers OTC contraception like Opill at no cost, and also that we find alternative pathways for people who don’t have insurance and who have low income,” said Dana Singiser, co-founder of the nonprofit Contraceptive Access Initiative and a partner at Keefe Singiser Partners.

February 12, 2024

Videos

The path to FDA approval for the combined oral contraceptive (COC)

A second over-the-counter birth control pill — the type used by over 90% of birth control pill users — is poised to achieve FDA approval. Learn about the FDA process and what to expect as “Zena” makes its way through the regulatory process.

The roadmap to affordable contraception

Momentum is building toward true affordability for over-the-counter (OTC) contraception! This short video simplifies the complex process behind truly affordable OTC access to the birth control pill. CAI co-founder Dana Singiser, the author of the Roadmap to Affordability, narrates the video. Expanding no-cost insurance access to over-the-counter contraceptives will impact nearly 60 million additional women of reproductive age. Explore CAI’s groundbreaking report on the impact of the Roadmap to Affordability. Learn more at thepillotc.org/affordability